Endomorphin 2 (trifluoroacetate salt) (Synonyms: Tyr-Pro-Phe-Phe-NH2) |
Catalog No.GC43603 |
Endomorphin 2 is an endogenous neuropeptide and μ-opioid receptor agonist (Ki = 0.69 nM) that has analgesic, negative reinforcing, and gastrointestinal properties.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Endomorphin 2 is an endogenous neuropeptide and μ-opioid receptor agonist (Ki = 0.69 nM) that has analgesic, negative reinforcing, and gastrointestinal properties.[1][2] It is found in the spinal cord and, to a lesser extent, in the brain. [3] It is selective for μ- over δ- and κ-opioid receptors (Kis = 9,233 and 5,240 nM, respectively). [1] Endomorphin 2 also binds to mouse brain membranes and rat recombinant μ-opioid receptors expressed in CHO cells (Kis = 1.37 and 0.58 nM, respectively).[2] It inhibits cAMP accumulation induced by forskolin in CHO cells expressing rat recombinant μ-opioid receptors and in SH-SY5Y human neuroblastoma cells (IC50s = 7.08 and 7.76 nM, respectively).[4] In mice, endomorphin 2 increases analgesia in a radiant heat tail-flick assay in mice following intracerebroventricular (i.c.v.) or intrathecal administration (ED50s = 1.99 and 3.81 μg, respectively) and induces conditioned place aversion when administered intracerebroventricularly at a dose of 10 μg. [2]It also decreases gastrointestinal transit time in mice when administered intracerebroventricularly at a dose of 3 μg.[2]
Reference:
[1]. Zadina, J.E., Hackler, L., Ge, L.J., et al. A potent and selective endogenous agonist for the µ-opiate receptor. Nature 386(6624), 499-502 (1997).
[2]. Goldberg, I.E., Rossi, G.C., Letchworth, S.R., et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther. 286(2), 1007-1013 (1998).
[3]. Martin-Schild, S., Gerall, A.A., Kastin, A.J., et al. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405(4), 450-471 (1999).
[4]. Harrison, C., McNulty, S., Smart, D., et al. The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant μ-opioid receptors and SH-SY5Y cells. Br. J. Pharmacol. 128(2), 472-478 (1999).
Average Rating: 5
(Based on Reviews and 15 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *